EPLERENONE

EPLERENONE was reported 13080 times

EPLERENONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COMPUTERISED TOMOGRAM CORONARY ARTERY ABNORMAL 19 0.2836
1 LIVER PALPABLE 20 0.2817
2 PLATELET DISTRIBUTION WIDTH INCREASED 13 0.2549
3 HEPATIC VEIN DILATATION 16 0.2222
4 DEGENERATIVE AORTIC VALVE DISEASE 13 0.1940
5 VENTRICULAR ENLARGEMENT 33 0.1875
6 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE ABNORMAL 14 0.1795
7 ATRIAL ENLARGEMENT 42 0.1544
8 RENAL PHOSPHOLIPIDOSIS 20 0.1471
9 GLOMERULAR FILTRATION RATE 10 0.1370
10 PYONEPHROSIS 11 0.1325
11 DUCHENNE MUSCULAR DYSTROPHY 10 0.1075
12 THERAPEUTIC DRUG MONITORING ANALYSIS INCORRECTLY PERFORMED 10 0.1053
13 COMPUTERISED TOMOGRAM HEART ABNORMAL 8 0.0976
14 INFERIOR VENA CAVA DILATATION 20 0.0948
15 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 43 0.0822
16 LEFT VENTRICULAR ENLARGEMENT 20 0.0784
17 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 110 0.0783
18 LOW CARDIAC OUTPUT SYNDROME 24 0.0719
19 SOFT TISSUE MASS 33 0.0714
20 MITRAL VALVE THICKENING 21 0.0705
21 BLOOD LACTIC ACID 9 0.0698
22 CARDIAC FAILURE CHRONIC 274 0.0642
23 CELLULITIS GANGRENOUS 12 0.0609
24 VENOUS PRESSURE JUGULAR INCREASED 21 0.0579
25 NONALCOHOLIC FATTY LIVER DISEASE 11 0.0561
26 MEAN CELL HAEMOGLOBIN CONCENTRATION ABNORMAL 9 0.0559
27 LEFT VENTRICULAR DILATATION 26 0.0509
28 THERAPEUTIC DRUG MONITORING ANALYSIS NOT PERFORMED 15 0.0508
29 LEFT ATRIAL ENLARGEMENT 26 0.0482
30 VENTRICULAR DYSKINESIA 10 0.0481
31 CARDIAC AMYLOIDOSIS 52 0.0472
32 ARRHYTHMIC STORM 15 0.0449
33 TYPE V HYPERLIPIDAEMIA 20 0.0412
34 MORGANELLA INFECTION 12 0.0410
35 OESOPHAGEAL PERFORATION 34 0.0408
36 JUGULAR VEIN DISTENSION 23 0.0406
37 BRONCHIAL HYPERREACTIVITY 45 0.0374
38 RESPIRATORY TRACT HAEMORRHAGE 22 0.0369
39 DILATED CARDIOMYOPATHY 37 0.0366
40 MITRAL VALVE CALCIFICATION 23 0.0358
41 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 8 0.0351
42 HYPERALDOSTERONISM 12 0.0348
43 HEART FAILURE WITH PRESERVED EJECTION FRACTION 10 0.0340
44 HYPOALDOSTERONISM 9 0.0328
45 ISCHAEMIC CARDIOMYOPATHY 99 0.0323
46 CARDIAC VENTRICULAR DISORDER 13 0.0316
47 MULTIMORBIDITY 33 0.0276
48 RALES 158 0.0272
49 PULMONARY FUNCTION TEST ABNORMAL 42 0.0269
50 NON-ALCOHOLIC FATTY LIVER 9 0.0267
51 DYSPNOEA AT REST 72 0.0248
52 RIGHT VENTRICULAR DYSFUNCTION 26 0.0236
53 OCULAR MYASTHENIA 8 0.0233
54 PULMONARY ARTERIAL PRESSURE INCREASED 37 0.0227
55 CARDIORENAL SYNDROME 13 0.0227
56 SUPERINFECTION 34 0.0227
57 DERMO-HYPODERMITIS 13 0.0218
58 SUBCLAVIAN VEIN THROMBOSIS 24 0.0211
59 VENTRICULAR ARRHYTHMIA 77 0.0210
60 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 9 0.0202
61 MICTURITION FREQUENCY DECREASED 15 0.0200
62 HEART FAILURE WITH REDUCED EJECTION FRACTION 10 0.0187
63 ORTHOPNOEA 59 0.0185
64 HYPERTROPHY 10 0.0184
65 SCROTAL OEDEMA 13 0.0183
66 CARDIAC ANEURYSM 18 0.0181
67 EXERCISE TOLERANCE DECREASED 103 0.0179
68 DYSPNOEA PAROXYSMAL NOCTURNAL 13 0.0178
69 HEART TRANSPLANT 16 0.0177
70 VENTRICULAR HYPOKINESIA 56 0.0174
71 CARDIAC FAILURE ACUTE 116 0.0174
72 GLOMERULAR FILTRATION RATE ABNORMAL 23 0.0162
73 MITRAL VALVE INCOMPETENCE 183 0.0162
74 ATRIAL THROMBOSIS 33 0.0159
75 CONGESTIVE CARDIOMYOPATHY 66 0.0158
76 CONTRAINDICATED DRUG ADMINISTERED 11 0.0157
77 EJECTION FRACTION DECREASED 241 0.0155
78 STENOSIS 29 0.0154
79 VENTRICULAR TACHYCARDIA 253 0.0153
80 LEFT ATRIAL DILATATION 19 0.0149
81 WAIST CIRCUMFERENCE INCREASED 15 0.0145
82 HYDROTHORAX 12 0.0145
83 CARDIAC VENTRICULAR THROMBOSIS 18 0.0139
84 TRANSPLANT FAILURE 34 0.0139
85 ATRIAL TACHYCARDIA 29 0.0138
86 AORTIC VALVE SCLEROSIS 10 0.0136
87 GLOMERULAR FILTRATION RATE DECREASED 164 0.0133
88 GLOMERULAR FILTRATION RATE INCREASED 11 0.0133
89 BRAIN NATRIURETIC PEPTIDE INCREASED 41 0.0133
90 LUNG CONSOLIDATION 37 0.0132
91 BREATH SOUNDS ABNORMAL 65 0.0132
92 LEFT VENTRICULAR DYSFUNCTION 88 0.0131
93 CONDUCTION DISORDER 24 0.0131
94 TRICUSPID VALVE INCOMPETENCE 104 0.0131
95 GENITAL SWELLING 9 0.0130
96 CARDIOACTIVE DRUG LEVEL INCREASED 17 0.0129
97 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 41 0.0124
98 HYPERKALAEMIA 427 0.0122
99 CORONARY ARTERY STENOSIS 61 0.0121
100 CARDIAC FAILURE 969 0.0121
101 RENAL ATROPHY 15 0.0120
102 HYPERURICAEMIA 48 0.0117
103 BLOOD PRESSURE SYSTOLIC DECREASED 53 0.0116
104 AORTIC VALVE INCOMPETENCE 49 0.0115
105 BRASH SYNDROME 16 0.0114
106 VASCULAR STENT THROMBOSIS 23 0.0113
107 HYPOVOLAEMIA 66 0.0113
108 HYPOPERFUSION 11 0.0105
109 QRS AXIS ABNORMAL 8 0.0104
110 CARDIOMYOPATHY 153 0.0103
111 BUNDLE BRANCH BLOCK LEFT 42 0.0099
112 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 87 0.0098
113 CARDIOVASCULAR INSUFFICIENCY 16 0.0098
114 EJECTION FRACTION ABNORMAL 12 0.0098
115 BALANOPOSTHITIS 8 0.0097
116 GASTRIC DILATATION 16 0.0096
117 RECTAL ABSCESS 15 0.0089
118 SINUS NODE DYSFUNCTION 16 0.0087
119 LEFT VENTRICULAR HYPERTROPHY 37 0.0086
120 TACHYARRHYTHMIA 21 0.0084
121 BLOOD LOSS ANAEMIA 19 0.0084
122 VENTRICULAR EXTRASYSTOLES 87 0.0084
123 CONCOMITANT DISEASE AGGRAVATED 51 0.0083
124 SUPRAVENTRICULAR EXTRASYSTOLES 27 0.0080
125 ATRIAL FLUTTER 63 0.0079
126 DIABETIC FOOT 24 0.0078
127 CARDIOGENIC SHOCK 112 0.0078
128 CREPITATIONS 23 0.0077
129 ADRENOCORTICAL INSUFFICIENCY ACUTE 15 0.0077
130 WOUND HAEMORRHAGE 28 0.0076
131 AMYLOIDOSIS 13 0.0075
132 CARDIOMEGALY 92 0.0075
133 RIGHT VENTRICULAR FAILURE 52 0.0074
134 ELECTROCARDIOGRAM ABNORMAL 57 0.0073
135 INFLAMMATORY MARKER INCREASED 36 0.0073
136 NEPHROSCLEROSIS 8 0.0072
137 MYOCARDIAL ISCHAEMIA 82 0.0072
138 CARDIAC HYPERTROPHY 8 0.0072
139 VASCULAR PURPURA 10 0.0072
140 BLOOD PRESSURE INADEQUATELY CONTROLLED 43 0.0071
141 BLOOD POTASSIUM ABNORMAL 19 0.0071
142 NOCTURNAL DYSPNOEA 9 0.0071
143 LEFT VENTRICULAR FAILURE 24 0.0070
144 VENTRICULAR DYSFUNCTION 18 0.0069
145 ACUTE PRERENAL FAILURE 8 0.0069
146 MACROCYTOSIS 8 0.0069
147 DRUG CLEARANCE DECREASED 9 0.0069
148 AORTIC STENOSIS 24 0.0069
149 INTRACARDIAC THROMBUS 21 0.0068
150 DIASTOLIC DYSFUNCTION 21 0.0068
151 POLYCYTHAEMIA 14 0.0068
152 VENTRICULAR FIBRILLATION 75 0.0067
153 LABILE BLOOD PRESSURE 8 0.0067
154 DILATATION VENTRICULAR 14 0.0067
155 RHONCHI 9 0.0065
156 HYPERVOLAEMIA 32 0.0065
157 POLYURIA 53 0.0065
158 ACUTE KIDNEY INJURY 984 0.0064
159 CHORIORETINOPATHY 9 0.0063
160 PRODUCT MONITORING ERROR 9 0.0062
161 HAEMATOCRIT INCREASED 14 0.0061
162 VASOPLEGIA SYNDROME 10 0.0061
163 BLOOD POTASSIUM INCREASED 99 0.0061
164 FEMORAL NECK FRACTURE 31 0.0060
165 HYPOMAGNESAEMIA 84 0.0060
166 BENIGN PROSTATIC HYPERPLASIA 31 0.0060
167 PULMONARY CONGESTION 79 0.0060
168 BODY MASS INDEX INCREASED 8 0.0059
169 ELECTROCARDIOGRAM T WAVE INVERSION 13 0.0059
170 RENAL ARTERY STENOSIS 8 0.0058
171 AKINESIA 12 0.0058
172 DYSPNOEA EXERTIONAL 216 0.0057
173 CARDIAC DYSFUNCTION 21 0.0056
174 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 28 0.0055
175 MONOCYTE COUNT INCREASED 20 0.0055
176 BRADYCARDIA 290 0.0055
177 CAROTID ARTERY STENOSIS 19 0.0054
178 ELECTROLYTE IMBALANCE 63 0.0054
179 EOSINOPHILIA 95 0.0054
180 TROPONIN I INCREASED 9 0.0054
181 ACUTE PULMONARY OEDEMA 30 0.0053
182 HAEMOGLOBIN INCREASED 24 0.0053
183 HYPERTHYROIDISM 76 0.0052
184 HYPOVOLAEMIC SHOCK 25 0.0052
185 SPINAL STENOSIS 21 0.0051
186 SINUS BRADYCARDIA 49 0.0051
187 ORTHOSTATIC HYPOTENSION 88 0.0050
188 INTERMITTENT CLAUDICATION 8 0.0050
189 RENAL TUBULAR ACIDOSIS 11 0.0050
190 RENAL CYST 40 0.0050
191 HYPOTONIA 50 0.0050
192 BLOOD THYROID STIMULATING HORMONE INCREASED 46 0.0050
193 ERYSIPELAS 25 0.0050
194 HYPOCALCAEMIA 94 0.0050
195 CHEST INJURY 10 0.0048
196 SUDDEN CARDIAC DEATH 16 0.0047
197 PRURITUS GENITAL 11 0.0047
198 ARTERIAL THROMBOSIS 9 0.0047
199 EMBOLISM VENOUS 14 0.0046
200 PENILE PAIN 14 0.0046
201 BICYTOPENIA 9 0.0046
202 OCCULT BLOOD POSITIVE 9 0.0046
203 HEART VALVE INCOMPETENCE 13 0.0045
204 ATRIAL FIBRILLATION 440 0.0045
205 ESCHERICHIA SEPSIS 13 0.0045
206 HYPOTENSION 896 0.0045
207 NIPPLE PAIN 9 0.0044
208 OEDEMA PERIPHERAL 537 0.0044
209 IMMUNE-MEDIATED LUNG DISEASE 8 0.0044
210 ANGINA PECTORIS 125 0.0044
211 INTERNATIONAL NORMALISED RATIO ABNORMAL 15 0.0044
212 MICROCYTIC ANAEMIA 9 0.0043
213 HEART RATE ABNORMAL 24 0.0043
214 HYPERTENSIVE HEART DISEASE 8 0.0043
215 PROSTATITIS 13 0.0043
216 PULMONARY OEDEMA 191 0.0043
217 ARTERIOSCLEROSIS CORONARY ARTERY 28 0.0042
218 POOR PERIPHERAL CIRCULATION 18 0.0042
219 MELAENA 93 0.0042
220 OBSTRUCTIVE AIRWAYS DISORDER 47 0.0042
221 ANAEMIA MACROCYTIC 9 0.0042
222 TROPONIN INCREASED 32 0.0042
223 HYPOPHOSPHATAEMIA 31 0.0042
224 SUBDURAL HAEMATOMA 60 0.0042
225 HYPERSENSITIVITY VASCULITIS 11 0.0042
226 POTENTIATING DRUG INTERACTION 14 0.0042
227 GASTROINTESTINAL NECROSIS 12 0.0041
228 PERICARDIAL HAEMORRHAGE 9 0.0041
229 CIRCULATORY COLLAPSE 70 0.0041
230 CONCOMITANT DISEASE PROGRESSION 8 0.0041
231 RED CELL DISTRIBUTION WIDTH INCREASED 17 0.0041
232 BLOOD CREATININE ABNORMAL 14 0.0040
233 TACHYPNOEA 55 0.0040
234 CARDIAC MURMUR 35 0.0040
235 SUBDURAL HAEMORRHAGE 11 0.0040
236 HYPONATRAEMIA 226 0.0040
237 ATRIOVENTRICULAR BLOCK 31 0.0040
238 BLOOD UREA INCREASED 67 0.0040
239 PROTEIN TOTAL DECREASED 15 0.0040
240 CORONARY ARTERY OCCLUSION 54 0.0039
241 HIGH DENSITY LIPOPROTEIN DECREASED 13 0.0039
242 BLOOD CREATININE INCREASED 253 0.0039
243 PROTHROMBIN TIME PROLONGED 23 0.0038
244 BLOOD CREATINE INCREASED 17 0.0038
245 URINARY TRACT OBSTRUCTION 9 0.0038
246 LUNG OPACITY 10 0.0038
247 UROSEPSIS 35 0.0038
248 OXYGEN CONSUMPTION INCREASED 9 0.0038
249 HYPOKALAEMIA 172 0.0037
250 MYOPATHY 32 0.0037
251 RENAL IMPAIRMENT 311 0.0037
252 GLOMERULONEPHRITIS 9 0.0037
253 HAEMORRHAGE SUBCUTANEOUS 13 0.0037
254 PULMONARY HYPERTENSION 76 0.0036
255 DIABETIC NEUROPATHY 18 0.0036
256 ARRHYTHMIA 172 0.0036
257 IRON DEFICIENCY ANAEMIA 33 0.0036
258 GOUT 64 0.0036
259 IRON DEFICIENCY 16 0.0036
260 AZOTAEMIA 14 0.0035
261 CREATININE RENAL CLEARANCE DECREASED 14 0.0035
262 PERIPHERAL VASCULAR DISORDER 18 0.0035
263 NON-CARDIAC CHEST PAIN 11 0.0035
264 ASCITES 102 0.0035
265 DRUG INTERACTION 550 0.0035
266 BLOOD PRESSURE DECREASED 230 0.0035
267 ACUTE MYOCARDIAL INFARCTION 102 0.0035
268 URINE OUTPUT INCREASED 9 0.0034
269 HAEMODYNAMIC INSTABILITY 26 0.0034
270 PRODUCT PRESCRIBING ERROR 81 0.0034
271 ANGINA UNSTABLE 22 0.0034
272 PULMONARY ARTERIAL HYPERTENSION 49 0.0034
273 PLEURAL EFFUSION 204 0.0033
274 MIXED LIVER INJURY 10 0.0033
275 DRUG LEVEL INCREASED 55 0.0033
276 LARGE INTESTINE POLYP 23 0.0033
277 ATRIOVENTRICULAR BLOCK SECOND DEGREE 10 0.0033
278 HEPATOMEGALY 32 0.0033
279 CONTRAINDICATED PRODUCT ADMINISTERED 98 0.0032
280 FLUID OVERLOAD 47 0.0032
281 CARDIAC FAILURE CONGESTIVE 256 0.0032
282 IMMUNE THROMBOCYTOPENIC PURPURA 9 0.0032
283 DERMATOMYOSITIS 8 0.0032
284 PERIPHERAL COLDNESS 43 0.0031
285 RENAL FAILURE CHRONIC 24 0.0031
286 BLOOD URIC ACID INCREASED 18 0.0031
287 BLOOD CHLORIDE DECREASED 8 0.0031
288 VARICOSE VEIN 16 0.0031
289 SHOCK HAEMORRHAGIC 25 0.0031
290 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 10 0.0030
291 PROTEIN TOTAL INCREASED 8 0.0030
292 RESPIRATORY SYNCYTIAL VIRUS INFECTION 26 0.0030
293 HYPERLACTACIDAEMIA 8 0.0030
294 BREAST SWELLING 8 0.0030
295 CHEST X-RAY ABNORMAL 9 0.0029
296 HEART RATE IRREGULAR 66 0.0029
297 PEMPHIGOID 22 0.0029
298 HEPATIC CYTOLYSIS 37 0.0029
299 HYPOPNOEA 10 0.0029
300 GYNAECOMASTIA 89 0.0029
301 CORONARY ARTERY DISEASE 87 0.0029
302 ATRIOVENTRICULAR BLOCK COMPLETE 19 0.0028
303 RASH MACULO-PAPULAR 63 0.0028
304 INTERNATIONAL NORMALISED RATIO INCREASED 80 0.0028
305 DUODENAL ULCER HAEMORRHAGE 8 0.0028
306 PARAPLEGIA 8 0.0028
307 ARTERIOSCLEROSIS 26 0.0028
308 STRESS CARDIOMYOPATHY 16 0.0027
309 URINE OUTPUT DECREASED 24 0.0027
310 UPPER GASTROINTESTINAL HAEMORRHAGE 46 0.0027
311 SPLENOMEGALY 32 0.0027
312 BLOOD PRESSURE DIASTOLIC DECREASED 20 0.0027
313 MYOCARDITIS 31 0.0027
314 HEPATITIS FULMINANT 8 0.0027
315 ANXIETY DISORDER 9 0.0027
316 ELECTROCARDIOGRAM QT PROLONGED 96 0.0027
317 RENAL FAILURE ACUTE 113 0.0027
318 SYNCOPE 266 0.0027
319 CHOLESTASIS 51 0.0027
320 HAEMOPTYSIS 74 0.0027
321 BLOOD SODIUM DECREASED 50 0.0026
322 DYSAESTHESIA 8 0.0026
323 DUODENITIS 8 0.0026
324 DERMATITIS EXFOLIATIVE 13 0.0026
325 RENAL FUNCTION TEST ABNORMAL 12 0.0026
326 EXTRASYSTOLES 18 0.0026
327 HYPOGLYCAEMIA 125 0.0026
328 GENERAL PHYSICAL HEALTH DETERIORATION 296 0.0026
329 HYPOKINESIA 37 0.0025
330 ATRIOVENTRICULAR BLOCK FIRST DEGREE 11 0.0025
331 SKIN WEEPING 9 0.0025
332 DIVERTICULUM INTESTINAL 11 0.0025
333 SUPRAVENTRICULAR TACHYCARDIA 24 0.0025
334 GENERALISED OEDEMA 31 0.0025
335 DIZZINESS POSTURAL 24 0.0025
336 NOCTURIA 30 0.0025
337 FLUID RETENTION 124 0.0024
338 INFUSION SITE HAEMORRHAGE 8 0.0024
339 HAEMATOMA 63 0.0024
340 HYPERTENSIVE CRISIS 27 0.0024
341 EUGLYCAEMIC DIABETIC KETOACIDOSIS 10 0.0024
342 OEDEMA 131 0.0024
343 BEHAVIOUR DISORDER 13 0.0024
344 OBESITY 38 0.0024
345 NEPHROGENIC ANAEMIA 11 0.0024
346 CARDIAC PACEMAKER INSERTION 14 0.0023
347 SINUS TACHYCARDIA 33 0.0023
348 POISONING DELIBERATE 22 0.0023
349 CARDIAC TAMPONADE 11 0.0023
350 CARDIOPULMONARY FAILURE 9 0.0023
351 BLOOD LACTIC ACID INCREASED 12 0.0023
352 CORONAVIRUS INFECTION 15 0.0023
353 LUNG TRANSPLANT 8 0.0023
354 FIBRIN D DIMER INCREASED 8 0.0022
355 HEPATIC ENCEPHALOPATHY 21 0.0022
356 HAEMORRHAGIC DIATHESIS 8 0.0022
357 STAPHYLOCOCCAL SEPSIS 11 0.0022
358 DECREASED ACTIVITY 24 0.0022
359 MULTIPLE INJURIES 14 0.0022
360 INTERNATIONAL NORMALISED RATIO DECREASED 9 0.0022
361 GLYCOSYLATED HAEMOGLOBIN INCREASED 56 0.0022
362 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 9 0.0022
363 DIABETES MELLITUS INADEQUATE CONTROL 39 0.0022
364 COVID-19 PNEUMONIA 26 0.0022
365 PNEUMOCYSTIS JIROVECII PNEUMONIA 22 0.0022
366 CHOLECYSTITIS 26 0.0022
367 ODYNOPHAGIA 13 0.0022
368 BLOOD POTASSIUM DECREASED 65 0.0022
369 LOCALISED OEDEMA 10 0.0022
370 SUBARACHNOID HAEMORRHAGE 22 0.0022
371 VITAMIN D DEFICIENCY 21 0.0022
372 CACHEXIA 11 0.0021
373 HYPOTHYROIDISM 68 0.0021
374 HEPATIC NECROSIS 8 0.0021
375 PRE-ECLAMPSIA 10 0.0021
376 NEUTROPENIC SEPSIS 15 0.0021
377 COLD SWEAT 37 0.0021
378 INFUSION SITE PAIN 27 0.0021
379 OLIGURIA 13 0.0021
380 ANURIA 18 0.0021
381 GAMMA-GLUTAMYLTRANSFERASE INCREASED 46 0.0021
382 DEHYDRATION 275 0.0021
383 EPISTAXIS 154 0.0021
384 RENAL FAILURE 273 0.0021
385 MALNUTRITION 23 0.0021
386 DYSPNOEA 1162 0.0021
387 EPIGASTRIC DISCOMFORT 8 0.0020
388 ISCHAEMIC STROKE 36 0.0020
389 HYPERLIPIDAEMIA 24 0.0020
390 ARTERIOSPASM CORONARY 8 0.0020
391 DUODENAL ULCER 14 0.0020
392 INGUINAL HERNIA 12 0.0020
393 HYPERTHERMIA 15 0.0020
394 HAEMATURIA 67 0.0020
395 ACUTE CORONARY SYNDROME 16 0.0019
396 GASTRITIS EROSIVE 9 0.0019
397 LOWER RESPIRATORY TRACT INFECTION 87 0.0019
398 SUDDEN DEATH 20 0.0019
399 GESTATIONAL DIABETES 9 0.0019
400 AGRANULOCYTOSIS 35 0.0019
401 PRODUCT ADMINISTRATION ERROR 38 0.0019
402 GASTROINTESTINAL HAEMORRHAGE 156 0.0019
403 ANAL FISSURE 10 0.0019
404 HYPERCHOLESTEROLAEMIA 18 0.0019
405 LACTIC ACIDOSIS 60 0.0019
406 CHRONIC KIDNEY DISEASE 139 0.0018
407 HAEMORRHAGIC ANAEMIA 8 0.0018
408 BREAST PAIN 19 0.0018
409 GASTROENTERITIS 26 0.0018
410 HEART RATE DECREASED 62 0.0018
411 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 9 0.0018
412 ALTERED STATE OF CONSCIOUSNESS 38 0.0018
413 ANAEMIA 334 0.0017
414 CEREBRAL ISCHAEMIA 9 0.0017
415 INFUSION SITE SWELLING 11 0.0017
416 VENTRICULAR SEPTAL DEFECT 10 0.0017
417 PHOTOPSIA 11 0.0017
418 PERFORMANCE STATUS DECREASED 8 0.0017
419 HEPATOCELLULAR INJURY 24 0.0017
420 METABOLIC ACIDOSIS 54 0.0017
421 VERTIGO 102 0.0017
422 GASTRITIS 44 0.0017
423 ACUTE RESPIRATORY FAILURE 32 0.0017
424 PRESYNCOPE 40 0.0016
425 TACHYCARDIA 146 0.0016
426 TENSION 10 0.0016
427 BLOOD PRESSURE SYSTOLIC INCREASED 32 0.0016
428 TYPE 2 DIABETES MELLITUS 55 0.0016
429 PSEUDOMONAS INFECTION 14 0.0016
430 SEPTIC SHOCK 71 0.0016
431 PALPITATIONS 191 0.0016
432 SKIN ULCER 42 0.0016
433 LOWER GASTROINTESTINAL HAEMORRHAGE 12 0.0016
434 GENERAL PHYSICAL CONDITION ABNORMAL 11 0.0016
435 SPINAL PAIN 19 0.0016
436 PALLOR 44 0.0016
437 CARDIAC DISORDER 151 0.0016
438 ABNORMAL LOSS OF WEIGHT 11 0.0016
439 CARDIAC ARREST 133 0.0016
440 BLOOD CALCIUM DECREASED 18 0.0016
441 FLUID INTAKE REDUCED 8 0.0016
442 CEREBRAL INFARCTION 39 0.0016
443 INTERSTITIAL LUNG DISEASE 77 0.0016
444 URINARY RETENTION 53 0.0016
445 EMPHYSEMA 16 0.0016
446 LIPASE INCREASED 12 0.0016
447 PULMONARY FIBROSIS 30 0.0016
448 ENDOCARDITIS 8 0.0016
449 MUSCULOSKELETAL CHEST PAIN 24 0.0015
450 LOW DENSITY LIPOPROTEIN INCREASED 12 0.0015
451 SMALL INTESTINAL OBSTRUCTION 19 0.0015
452 INFUSION SITE ERYTHEMA 13 0.0015
453 BRONCHOSPASM 22 0.0015
454 HAEMORRHOIDS 30 0.0015
455 WEIGHT FLUCTUATION 16 0.0015
456 VISUAL FIELD DEFECT 11 0.0015
457 POLLAKIURIA 63 0.0015
458 INTENTIONAL DOSE OMISSION 43 0.0015
459 BLOOD PRESSURE FLUCTUATION 36 0.0015
460 HAEMATEMESIS 38 0.0015
461 RESPIRATORY TRACT INFECTION 39 0.0015
462 HEPATIC CIRRHOSIS 28 0.0015
463 PLATELET COUNT ABNORMAL 9 0.0015
464 JAUNDICE 40 0.0015
465 MYASTHENIA GRAVIS 12 0.0015
466 C-REACTIVE PROTEIN INCREASED 54 0.0015
467 PROTEINURIA 28 0.0015
468 PNEUMONITIS 40 0.0015
469 ACUTE HEPATIC FAILURE 20 0.0015
470 BLOOD TESTOSTERONE DECREASED 10 0.0015
471 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15 0.0015
472 BREAST TENDERNESS 11 0.0015
473 ILEUS 18 0.0014
474 HYPERBILIRUBINAEMIA 15 0.0014
475 AORTIC ANEURYSM 11 0.0014
476 BLOOD BILIRUBIN INCREASED 39 0.0014
477 RENAL TUBULAR NECROSIS 14 0.0014
478 PERIORBITAL SWELLING 8 0.0014
479 HAEMATOCHEZIA 78 0.0014
480 THERMAL BURN 10 0.0014
481 HAEMORRHAGIC STROKE 11 0.0014
482 TRANSAMINASES INCREASED 31 0.0014
483 DIARRHOEA HAEMORRHAGIC 13 0.0014
484 FAECES DISCOLOURED 30 0.0014
485 DIZZINESS 688 0.0014
486 ABSCESS 22 0.0014
487 LIVER FUNCTION TEST ABNORMAL 40 0.0014
488 SEPSIS 153 0.0014
489 RHABDOMYOLYSIS 57 0.0014
490 APPETITE DISORDER 9 0.0014
491 PURPURA 12 0.0014
492 DRUG PRESCRIBING ERROR 26 0.0014
493 POOR VENOUS ACCESS 14 0.0014
494 HEART RATE INCREASED 134 0.0014
495 WEIGHT INCREASED 302 0.0013
496 RESPIRATORY FAILURE 98 0.0013
497 PERICARDIAL EFFUSION 31 0.0013
498 PRODUCTIVE COUGH 64 0.0013
499 ERECTILE DYSFUNCTION 34 0.0013
500 HEMIPLEGIA 11 0.0013
501 CHEST DISCOMFORT 135 0.0013
502 OESOPHAGEAL CARCINOMA 39 0.0013
503 INFARCTION 9 0.0013
504 RIB FRACTURE 27 0.0013
505 PAIN IN JAW 37 0.0013
506 RETINAL DETACHMENT 12 0.0013
507 JOINT EFFUSION 9 0.0013
508 PRESCRIBED UNDERDOSE 26 0.0013
509 ABDOMINAL DISTENSION 134 0.0013
510 FALL 427 0.0013
511 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 33 0.0013
512 BLOOD MAGNESIUM DECREASED 11 0.0013
513 PULMONARY TOXICITY 9 0.0013
514 CONDITION AGGRAVATED 386 0.0013
515 PYELONEPHRITIS 11 0.0013
516 DYSSTASIA 37 0.0013
517 DIVERTICULUM 9 0.0013
518 DISTURBANCE IN ATTENTION 68 0.0013
519 HAEMATOCRIT DECREASED 25 0.0013
520 BLOOD ALBUMIN DECREASED 10 0.0013
521 COAGULOPATHY 21 0.0013
522 SLEEP APNOEA SYNDROME 24 0.0013
523 HYPOPHAGIA 32 0.0013
524 ASTHENIA 470 0.0012
525 BLOOD DISORDER 10 0.0012
526 HAEMOGLOBIN DECREASED 128 0.0012
527 CHEST PAIN 230 0.0012
528 RHINITIS 10 0.0012
529 FRUSTRATION TOLERANCE DECREASED 10 0.0012
530 CARDIAC FLUTTER 8 0.0012
531 DECUBITUS ULCER 10 0.0012
532 POLYP 8 0.0012
533 PERIPHERAL SWELLING 188 0.0012
534 DIABETES MELLITUS 93 0.0012
535 BLOOD URINE PRESENT 23 0.0012
536 PHOTOSENSITIVITY REACTION 20 0.0012
537 RECTAL HAEMORRHAGE 52 0.0012
538 KETOACIDOSIS 9 0.0012
539 COUGH 334 0.0012
540 BRONCHITIS 88 0.0012
541 PERSONALITY CHANGE 11 0.0012
542 MUSCLE ATROPHY 15 0.0012
543 HEPATIC STEATOSIS 22 0.0012
544 EYELID PTOSIS 12 0.0012
545 MYOCARDIAL INFARCTION 206 0.0012
546 THYROID DISORDER 18 0.0012
547 HELICOBACTER INFECTION 12 0.0012
548 CONCUSSION 9 0.0012
549 PNEUMONIA ASPIRATION 29 0.0012
550 BLOOD PRESSURE ABNORMAL 23 0.0012
551 APNOEA 9 0.0012
552 THERAPY PARTIAL RESPONDER 18 0.0012
553 HYPERTENSION 243 0.0011
554 CARPAL TUNNEL SYNDROME 16 0.0011
555 DYSURIA 42 0.0011
556 DYSPHAGIA 108 0.0011
557 HEAD INJURY 36 0.0011
558 HYPOXIA 40 0.0011
559 GASTRIC HAEMORRHAGE 13 0.0011
560 BLOOD ALKALINE PHOSPHATASE INCREASED 28 0.0011
561 OXYGEN SATURATION DECREASED 63 0.0011
562 BLOOD CREATINE PHOSPHOKINASE INCREASED 32 0.0011
563 SKIN LACERATION 12 0.0011
564 INTENTIONAL UNDERDOSE 8 0.0011
565 MULTIPLE ORGAN DYSFUNCTION SYNDROME 31 0.0011
566 MOUTH HAEMORRHAGE 8 0.0011
567 DEPRESSED LEVEL OF CONSCIOUSNESS 43 0.0011
568 LOSS OF CONSCIOUSNESS 139 0.0011
569 MYALGIA 183 0.0011
570 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
571 ERYTHEMA MULTIFORME 10 0.0011
572 THIRST 19 0.0011
573 MEDICATION ERROR 59 0.0011
574 CEREBRAL HAEMORRHAGE 38 0.0011
575 TREATMENT NONCOMPLIANCE 58 0.0011
576 SARS-COV-2 TEST POSITIVE 14 0.0011
577 MUSCLE SPASTICITY 13 0.0011
578 SKIN LESION 29 0.0011
579 TOXIC EPIDERMAL NECROLYSIS 16 0.0011
580 MICTURITION URGENCY 12 0.0010
581 RESTLESS LEGS SYNDROME 19 0.0010
582 PARAESTHESIA ORAL 15 0.0010
583 WEIGHT DECREASED 290 0.0010
584 FEEDING DISORDER 21 0.0010
585 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 54 0.0010
586 CELLULITIS 52 0.0010
587 HYPOALBUMINAEMIA 8 0.0010
588 LETHARGY 59 0.0010
589 PLATELET COUNT DECREASED 108 0.0010
590 HIATUS HERNIA 13 0.0010
591 BLOOD PRESSURE INCREASED 153 0.0010
592 ECONOMIC PROBLEM 15 0.0010
593 ORAL CANDIDIASIS 13 0.0010
594 DECREASED APPETITE 225 0.0010
595 THROMBOCYTOPENIA 108 0.0010
596 INTERNAL HAEMORRHAGE 11 0.0010
597 BASAL CELL CARCINOMA 15 0.0010
598 PNEUMONIA 311 0.0010
599 APHASIA 29 0.0010
600 EOSINOPHIL COUNT INCREASED 8 0.0010
601 SHOCK 22 0.0010
602 TRANSFUSION 10 0.0010
603 GINGIVAL BLEEDING 13 0.0010
604 CARDIOVASCULAR DISORDER 24 0.0009
605 HEMIPARESIS 16 0.0009
606 DRUG INTOLERANCE 91 0.0009
607 ASPARTATE AMINOTRANSFERASE INCREASED 50 0.0009
608 SCIATICA 15 0.0009
609 OSTEOMYELITIS 17 0.0009
610 HEPATITIS 24 0.0009
611 HAEMORRHAGE INTRACRANIAL 14 0.0009
612 END STAGE RENAL DISEASE 17 0.0009
613 ATELECTASIS 9 0.0009
614 HEPATIC FAILURE 28 0.0009
615 BLOOD IRON DECREASED 11 0.0009
616 ANGIOEDEMA 41 0.0009
617 MULTI-ORGAN FAILURE 16 0.0009
618 DIARRHOEA 597 0.0009
619 LIVER DISORDER 41 0.0009
620 BLOOD CHOLESTEROL INCREASED 43 0.0009
621 PHARYNGEAL SWELLING 9 0.0009
622 DIABETIC KETOACIDOSIS 22 0.0009
623 CARDIO-RESPIRATORY ARREST 38 0.0009
624 PRODUCT COMMUNICATION ISSUE 8 0.0009
625 ADRENAL INSUFFICIENCY 11 0.0009
626 HYPERGLYCAEMIA 33 0.0009
627 IMPAIRED QUALITY OF LIFE 13 0.0009
628 TENDONITIS 14 0.0009
629 FATIGUE 701 0.0009
630 ALANINE AMINOTRANSFERASE INCREASED 55 0.0009
631 BRAIN FOG 14 0.0009
632 TENDON RUPTURE 11 0.0009
633 ANAL INCONTINENCE 8 0.0009
634 HYPOTHERMIA 9 0.0009
635 SWELLING 83 0.0009
636 IMPAIRED HEALING 29 0.0009
637 EAR DISCOMFORT 9 0.0009
638 FEMUR FRACTURE 27 0.0009
639 PROSTATIC SPECIFIC ANTIGEN INCREASED 12 0.0009
640 THERAPEUTIC PRODUCT EFFECT DECREASED 39 0.0009
641 TINNITUS 40 0.0009
642 PETECHIAE 9 0.0009
643 DISEASE PROGRESSION 102 0.0009
644 HEPATIC FUNCTION ABNORMAL 32 0.0009
645 DEVICE OCCLUSION 12 0.0009
646 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
647 THERAPY NON-RESPONDER 38 0.0008
648 RETCHING 18 0.0008
649 COLITIS 32 0.0008
650 BACTERAEMIA 10 0.0008
651 AGEUSIA 21 0.0008
652 BODY HEIGHT DECREASED 9 0.0008
653 DEAFNESS 22 0.0008
654 NECK PAIN 47 0.0008
655 GAIT INABILITY 28 0.0008
656 HYPOACUSIS 36 0.0008
657 POLYNEUROPATHY 10 0.0008
658 MOBILITY DECREASED 60 0.0008
659 AFFECT LABILITY 8 0.0008
660 MUSCULAR WEAKNESS 94 0.0008
661 CONFUSIONAL STATE 133 0.0008
662 HALLUCINATION 62 0.0008
663 SLEEP DISORDER 58 0.0008
664 MUSCULOSKELETAL PAIN 43 0.0008
665 PREMATURE DELIVERY 13 0.0008
666 RENAL DISORDER 38 0.0008
667 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9 0.0008
668 PARANOIA 14 0.0008
669 SENSORY DISTURBANCE 13 0.0008
670 LIMB INJURY 22 0.0008
671 HYPERCALCAEMIA 10 0.0008
672 MOUTH ULCERATION 17 0.0008
673 URINARY TRACT INFECTION 137 0.0008
674 RESPIRATORY DISTRESS 22 0.0008
675 HAEMORRHAGE 83 0.0008
676 CHOLELITHIASIS 26 0.0008
677 FRACTURE 15 0.0008
678 SCAB 9 0.0008
679 INCREASED APPETITE 15 0.0008
680 DISORIENTATION 31 0.0008
681 DEPRESSED MOOD 41 0.0008
682 DIALYSIS 11 0.0008
683 MUSCLE SPASMS 142 0.0008
684 THROMBOSIS 62 0.0008
685 SWOLLEN TONGUE 24 0.0008
686 CHILLS 90 0.0008
687 ABDOMINAL PAIN 178 0.0008
688 PREMATURE BABY 23 0.0008
689 FOLLICULITIS 8 0.0008
690 ASTHMA 86 0.0008
691 MALAISE 331 0.0008
692 APATHY 11 0.0008
693 TOXICITY TO VARIOUS AGENTS 127 0.0008
694 CHROMATURIA 17 0.0008
695 SKIN DISORDER 25 0.0007
696 TRANSIENT ISCHAEMIC ATTACK 25 0.0007
697 FLATULENCE 42 0.0007
698 INSOMNIA 197 0.0007
699 GASTRIC ULCER 14 0.0007
700 INFLAMMATION 38 0.0007
701 LUNG DISORDER 36 0.0007
702 RED BLOOD CELL COUNT DECREASED 21 0.0007
703 PANCYTOPENIA 41 0.0007
704 POST PROCEDURAL COMPLICATION 14 0.0007
705 GASTROINTESTINAL PAIN 8 0.0007
706 SUICIDE ATTEMPT 44 0.0007
707 VIRAL INFECTION 24 0.0007
708 GASTROENTERITIS VIRAL 13 0.0007
709 PARAESTHESIA 113 0.0007
710 DERMATITIS ALLERGIC 9 0.0007
711 PANCREATITIS ACUTE 16 0.0007
712 CONTUSION 68 0.0007
713 PULMONARY EMBOLISM 67 0.0007
714 WHITE BLOOD CELL COUNT INCREASED 27 0.0007
715 ABDOMINAL DISCOMFORT 118 0.0007
716 PYREXIA 243 0.0007
717 ABDOMINAL PAIN UPPER 144 0.0007
718 HYPERSOMNIA 20 0.0007
719 BALANCE DISORDER 60 0.0007
720 PNEUMOTHORAX 11 0.0007
721 UPPER RESPIRATORY TRACT INFECTION 32 0.0007
722 DYSKINESIA 28 0.0007
723 CEREBROVASCULAR ACCIDENT 116 0.0007
724 EYE HAEMORRHAGE 9 0.0007
725 CATARACT 40 0.0007
726 COLON CANCER 10 0.0007
727 ACCIDENT 8 0.0007
728 CHOKING 13 0.0007
729 DYSARTHRIA 25 0.0007
730 INFLUENZA 74 0.0007
731 LEUKOCYTOSIS 12 0.0007
732 VISUAL IMPAIRMENT 82 0.0007
733 VOMITING 310 0.0007
734 DISCOMFORT 40 0.0007
735 RESPIRATORY DEPRESSION 8 0.0007
736 FACE OEDEMA 11 0.0007
737 NAUSEA 516 0.0007
738 DYSPHONIA 38 0.0006
739 PRURITUS GENERALISED 14 0.0006
740 RASH PRURITIC 35 0.0006
741 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
742 BONE MARROW FAILURE 13 0.0006
743 SEASONAL ALLERGY 9 0.0006
744 HYPOAESTHESIA 95 0.0006
745 FOOT FRACTURE 12 0.0006
746 NASAL CONGESTION 37 0.0006
747 PRURITUS 241 0.0006
748 HOT FLUSH 47 0.0006
749 DRUG RESISTANCE 16 0.0006
750 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
751 FEELING ABNORMAL 149 0.0006
752 HEAD DISCOMFORT 11 0.0006
753 ERUCTATION 12 0.0006
754 UNRESPONSIVE TO STIMULI 16 0.0006
755 INJECTION SITE INDURATION 8 0.0006
756 DIVERTICULITIS 17 0.0006
757 OSTEOARTHRITIS 26 0.0006
758 MUCOSAL INFLAMMATION 16 0.0006
759 PSYCHOTIC DISORDER 18 0.0006
760 METASTASES TO BONE 10 0.0006
761 WOUND 17 0.0006
762 BLOOD GLUCOSE INCREASED 114 0.0006
763 OROPHARYNGEAL PAIN 56 0.0006
764 SOMNOLENCE 121 0.0006
765 CONSTIPATION 131 0.0006
766 LIP SWELLING 20 0.0006
767 SWELLING FACE 39 0.0006
768 BACK PAIN 139 0.0006
769 CYSTITIS 19 0.0006
770 TASTE DISORDER 12 0.0006
771 WHEEZING 35 0.0006
772 DEVICE RELATED INFECTION 9 0.0006
773 GASTRIC DISORDER 20 0.0006
774 NIGHTMARE 20 0.0006
775 LABORATORY TEST ABNORMAL 17 0.0006
776 MENTAL DISORDER 25 0.0006
777 OFF LABEL USE 502 0.0006
778 SPEECH DISORDER 30 0.0006
779 PRODUCT USE COMPLAINT 9 0.0006
780 HYPERHIDROSIS 73 0.0006
781 MUSCLE TWITCHING 13 0.0006
782 EATING DISORDER 12 0.0006
783 SKIN FISSURES 11 0.0006
784 GAIT DISTURBANCE 107 0.0006
785 GASTROOESOPHAGEAL REFLUX DISEASE 45 0.0006
786 VISION BLURRED 76 0.0006
787 PRODUCT PRESCRIBING ISSUE 12 0.0006
788 ARTHRALGIA 228 0.0005
789 MANIA 9 0.0005
790 STAPHYLOCOCCAL INFECTION 18 0.0005
791 PRODUCT USE IN UNAPPROVED INDICATION 135 0.0005
792 RASH ERYTHEMATOUS 26 0.0005
793 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 98 0.0005
794 TREMOR 90 0.0005
795 TOOTH DISORDER 12 0.0005
796 NEUTROPENIA 73 0.0005
797 PAIN IN EXTREMITY 158 0.0005
798 NEUROPATHY PERIPHERAL 51 0.0005
799 HEADACHE 336 0.0005
800 GASTROINTESTINAL DISORDER 48 0.0005
801 COVID-19 94 0.0005
802 INCORRECT DRUG ADMINISTRATION DURATION 15 0.0005
803 ANHEDONIA 14 0.0005
804 DRY MOUTH 43 0.0005
805 ILLNESS 54 0.0005
806 DRUG EFFECT INCOMPLETE 19 0.0005
807 BLISTER 29 0.0005
808 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
809 PLASMA CELL MYELOMA 20 0.0005
810 DYSGEUSIA 38 0.0005
811 LYMPHOCYTE COUNT DECREASED 9 0.0005
812 ARTHRITIS 40 0.0005
813 LYMPHADENOPATHY 18 0.0005
814 UNDERDOSE 37 0.0005
815 FEELING HOT 31 0.0005
816 MENTAL STATUS CHANGES 14 0.0005
817 INTENTIONAL PRODUCT MISUSE 44 0.0005
818 SPINAL FRACTURE 10 0.0005
819 MENTAL IMPAIRMENT 12 0.0005
820 THERAPY CESSATION 25 0.0005
821 RASH MACULAR 17 0.0005
822 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
823 CYTOMEGALOVIRUS INFECTION 8 0.0005
824 BLOOD GLUCOSE DECREASED 23 0.0005
825 PHOTOPHOBIA 9 0.0005
826 NERVOUSNESS 25 0.0005
827 DERMATITIS 10 0.0005
828 DEPRESSION 108 0.0005
829 PANCREATITIS 25 0.0005
830 OVERDOSE 101 0.0005
831 DYSPEPSIA 46 0.0005
832 IRRITABLE BOWEL SYNDROME 10 0.0005
833 LIVER FUNCTION TEST INCREASED 10 0.0005
834 IRRITABILITY 28 0.0005
835 ANAPHYLACTIC SHOCK 12 0.0005
836 MUSCULOSKELETAL DISCOMFORT 8 0.0005
837 ACCIDENTAL OVERDOSE 17 0.0005
838 POOR QUALITY SLEEP 10 0.0005
839 JOINT SWELLING 56 0.0005
840 ANXIETY 132 0.0005
841 ECZEMA 24 0.0005
842 LOCALISED INFECTION 11 0.0005
843 LIMB DISCOMFORT 14 0.0005
844 UPPER LIMB FRACTURE 9 0.0005
845 AGITATION 33 0.0004
846 CYTOKINE RELEASE SYNDROME 9 0.0004
847 FULL BLOOD COUNT DECREASED 9 0.0004
848 DRUG-INDUCED LIVER INJURY 14 0.0004
849 FEAR 12 0.0004
850 BODY TEMPERATURE INCREASED 9 0.0004
851 LEUKOPENIA 22 0.0004
852 PRODUCT DOSE OMISSION ISSUE 129 0.0004
853 VAGINAL HAEMORRHAGE 19 0.0004
854 RESTLESSNESS 16 0.0004
855 UNEVALUABLE EVENT 33 0.0004
856 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0004
857 DRY SKIN 58 0.0004
858 NASOPHARYNGITIS 80 0.0004
859 FLUSHING 44 0.0004
860 DELIRIUM 15 0.0004
861 MEMORY IMPAIRMENT 59 0.0004
862 DEMENTIA 12 0.0004
863 BACTERIAL INFECTION 8 0.0004
864 ERYTHEMA 88 0.0004
865 INJURY 30 0.0004
866 INFLUENZA LIKE ILLNESS 35 0.0004
867 THROAT IRRITATION 19 0.0004
868 PAIN 260 0.0004
869 JOINT INJURY 9 0.0004
870 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 23 0.0004
871 RHINORRHOEA 27 0.0004
872 ANAPHYLACTIC REACTION 23 0.0004
873 GLAUCOMA 8 0.0004
874 MATERNAL EXPOSURE DURING PREGNANCY 37 0.0004
875 NEPHROLITHIASIS 19 0.0004
876 PRESCRIBED OVERDOSE 8 0.0004
877 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
878 NEURALGIA 10 0.0004
879 BONE PAIN 24 0.0004
880 ENCEPHALOPATHY 10 0.0004
881 THROAT TIGHTNESS 11 0.0004
882 FOETAL EXPOSURE DURING PREGNANCY 33 0.0004
883 RASH 176 0.0004
884 NO ADVERSE EVENT 73 0.0004
885 RESPIRATORY DISORDER 12 0.0004
886 INFECTION 58 0.0004
887 AGGRESSION 20 0.0004
888 MUSCULOSKELETAL STIFFNESS 35 0.0004
889 DISEASE RECURRENCE 19 0.0004
890 DRUG INEFFECTIVE 524 0.0004
891 PRODUCT USE ISSUE 74 0.0004
892 NEUTROPHIL COUNT DECREASED 16 0.0004
893 EMOTIONAL DISORDER 12 0.0004
894 PRODUCT DOSE OMISSION IN ERROR 11 0.0004
895 DEVICE MALFUNCTION 27 0.0004
896 PRODUCT SUBSTITUTION ISSUE 22 0.0004
897 SEDATION 10 0.0004
898 HEPATIC ENZYME INCREASED 26 0.0004
899 HALLUCINATION, VISUAL 8 0.0004
900 EYE SWELLING 14 0.0004
901 EYE PAIN 21 0.0004
902 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 75 0.0004
903 SKIN DISCOLOURATION 17 0.0004
904 DEEP VEIN THROMBOSIS 24 0.0004
905 PRODUCT DISPENSING ERROR 8 0.0004
906 LIVER INJURY 9 0.0004
907 HERPES ZOSTER 21 0.0004
908 LACRIMATION INCREASED 11 0.0004
909 OSTEONECROSIS OF JAW 9 0.0004
910 RESPIRATORY ARREST 10 0.0004
911 ROAD TRAFFIC ACCIDENT 15 0.0004
912 AMNESIA 23 0.0004
913 NERVOUS SYSTEM DISORDER 11 0.0004
914 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
915 RASH GENERALISED 9 0.0003
916 DIPLOPIA 9 0.0003
917 INTESTINAL OBSTRUCTION 13 0.0003
918 BLINDNESS 14 0.0003
919 OSTEOPOROSIS 14 0.0003
920 HOSPITALISATION 52 0.0003
921 URINARY INCONTINENCE 10 0.0003
922 ALOPECIA 66 0.0003
923 THERAPY INTERRUPTED 24 0.0003
924 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
925 THERAPEUTIC RESPONSE DECREASED 20 0.0003
926 PANIC ATTACK 12 0.0003
927 ABNORMAL BEHAVIOUR 13 0.0003
928 INTENTIONAL OVERDOSE 21 0.0003
929 ANGER 11 0.0003
930 ARTHROPATHY 18 0.0003
931 MALIGNANT NEOPLASM PROGRESSION 33 0.0003
932 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
933 LUNG NEOPLASM MALIGNANT 13 0.0003
934 OCULAR HYPERAEMIA 15 0.0003
935 DEATH 269 0.0003
936 SINUSITIS 32 0.0003
937 HIP FRACTURE 10 0.0003
938 URTICARIA 52 0.0003
939 SKIN EXFOLIATION 26 0.0003
940 WHITE BLOOD CELL COUNT DECREASED 33 0.0003
941 FREQUENT BOWEL MOVEMENTS 8 0.0003
942 MOOD ALTERED 8 0.0003
943 ACNE 22 0.0003
944 FEELING COLD 8 0.0003
945 MOOD SWINGS 9 0.0003
946 EYE IRRITATION 16 0.0003
947 EYE DISORDER 9 0.0003
948 VISUAL ACUITY REDUCED 9 0.0003
949 EXPIRED PRODUCT ADMINISTERED 9 0.0003
950 NEOPLASM MALIGNANT 18 0.0003
951 SEIZURE 31 0.0003
952 INCORRECT DOSE ADMINISTERED 61 0.0003
953 EPILEPSY 8 0.0003
954 EXPOSURE DURING PREGNANCY 16 0.0003
955 BLADDER CANCER 15 0.0003
956 TREATMENT FAILURE 21 0.0003
957 MOVEMENT DISORDER 8 0.0002
958 NIGHT SWEATS 8 0.0002
959 PSORIATIC ARTHROPATHY 10 0.0002
960 DEVICE ISSUE 22 0.0002
961 SUICIDAL IDEATION 22 0.0002
962 COGNITIVE DISORDER 11 0.0002
963 HYPERSENSITIVITY 43 0.0002
964 ILL-DEFINED DISORDER 14 0.0002
965 COLORECTAL CANCER 11 0.0002
966 DEVICE DISLOCATION 10 0.0002
967 PSORIASIS 30 0.0002
968 DRUG EFFECT DECREASED 12 0.0002
969 PRODUCT DOSE OMISSION 14 0.0002
970 INFUSION RELATED REACTION 14 0.0002
971 FEBRILE NEUTROPENIA 14 0.0002
972 COMA 10 0.0002
973 DEVICE LEAKAGE 9 0.0002
974 COLITIS ULCERATIVE 9 0.0002
975 DRY EYE 10 0.0002
976 STOMATITIS 12 0.0002
977 EXTRA DOSE ADMINISTERED 8 0.0002
978 PROSTATE CANCER 15 0.0002
979 RHEUMATOID ARTHRITIS 21 0.0002
980 CONVULSION 10 0.0002
981 EMOTIONAL DISTRESS 21 0.0002
982 DRUG DOSE OMISSION 28 0.0002
983 INJECTION SITE BRUISING 13 0.0002
984 BURNING SENSATION 11 0.0002
985 SURGERY 9 0.0002
986 ADVERSE DRUG REACTION 13 0.0001
987 INJECTION SITE HAEMORRHAGE 11 0.0001
988 BREAST CANCER 12 0.0001
989 PRODUCT QUALITY ISSUE 17 0.0001
990 ADVERSE EVENT 11 0.0001
991 INJECTION SITE PAIN 34 0.0001
992 MIGRAINE 10 0.0001
993 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
994 DRUG ABUSE 8 0.0001
995 DRUG DEPENDENCE 10 0.0001